Par Drugs and Chemicals Limited — Others, 09-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Par Drugs and Chemicals Limited has announced a board meeting for the quarter ended December 31, 2024, regarding the compliance with Regulation 74(5) of SEBI regulations. The company confirms that securities received for dematerialization during this period have been processed accordingly, with proper listing on stock exchanges.

This update underscores the company’s commitment to regulatory compliance, ensuring that their securities management aligns with industry standards. For investors, this indicates a stable operational environment, fostering a positive outlook regarding governance and potential share liquidity.